Enhanced effect of myocardial gene transfection by VP22-mediated intercellular protein transport

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 4, 2004, Pages 603-606

  Suzuki, Ken ^a,b   Murtuza, Bari ^a   Brand, Nigel J ^a   Varela Carver, Anabel ^a   Fukushima, Satsuki ^a   Yacoub, Magdi H ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Harefield Heart Science Centre   (United Kingdom)

Author keywords

galactosidase; Gene transfection; Intercellular protein transport; VP22

Indexed keywords

BETA GALACTOSIDASE; HERPES SIMPLEX VIRUS PROTEIN VP 22; PLASMID VECTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENETIC CODE; GENETIC TRANSFECTION; HEART MUSCLE; HEART MUSCLE CELL; HERPES SIMPLEX VIRUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL NUCLEUS; CYTOPLASM; GENE THERAPY; GENE TRANSFER TECHNIQUES; LAC OPERON; MALE; MYOCARDIUM; POLYMERASE CHAIN REACTION; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFECTION; VIRAL PROTEINS;

SIMPLEXVIRUS;

EID: 1842765536     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.01.007     Document Type: Article

References (13)

1. Isner J.M. Myocardial gene therapy. Nature. 415:2002;234-239.
2. Huq F., Monte F.D., Hajjar R.J. Modulating signalling pathway in hypertrophy and heart failure by gene transfer. J Card Fail. 8:2002;S389-S400.
3. Ford K.G., Souberbielle B.E., Darling D., Farzaneh F. Protein transduction: an alternative to genetic intervention? Gene Ther. 8:2001;1-4.
4. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233.
5. Lai Z., Han I., Zirzow G., Brady R.O., Reise J. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc Natl Acad Sci USA. 97:2000;11297-11302.
6. Phelan A., Elliott G., O'Hare P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotech. 16:1998;440-443.
7. Zavaglia D., Favrot M.C., Eymin B., Tenaud C., Coll J.L. Intercellular trafficking and enhanced in vivo antitumor activity of a non-virally delivered P27-VP22 fusion protein. Gene Ther. 10:2003;314-325.
8. Zender L., Kock R., Eckhard M., Frericks B., Gosling T., Gebhardt T., Drobek S., Galanski M., Kuhnel F., Manns M., Kubicka S. Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterol. 123:2002;608-618.
9. Suzuki K., Brand N.J., Smolenski R.T., Jayakumar J., Murtuza B., Yacoub M.H. Development of a novel method for cell transplantation through the coronary artery. Circulation. 102:(suppl):2000;III359-III364.
10. Boenicke L., Chu K., Pauls R., Tams C., Kruse M.L., Kurdow R., Schniewind B., Bohle A., Kremer B., Kalthoff H. Efficient dose-dependent and time-dependent protein transduction of pancreatic carcinoma cells in vitro and in vivo using purified VP22-EGFP fusion protein. J Mol Med. 8:2003;205-213.
11. Normand N., van Leeuwen H., O'Hare P. Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J Biol Chem. 276:2001;15042-15050.
12. Suzuki K., Murtuza B., Smolenski R.T., Sammut I.A., Suzuki N., Kaneda Y., Yacoub M.H. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 104:(suppl):2001;I207-I212.
13. Kretz A., Wybranietz W.A., Hermening S., Lauer U.M., Isenmann S. HSV-1 VP22 augment adenoviral gene transfer to CNS neurons in the retina and striatum in vivo. Mol Ther. 7:2003;659-669.